Hepatitis viruses and hepatocellular carcinoma;Virus des hepatites et carcinome hepatocellulaire

Gastroenterologie Clinique et Biologique

Volumn 23, Issue 3, 1999, Pages 363-375

  Rosmorduc, Olivier ^a   Paterlini, Patricia ^b   Poupon, Raoul ^a   Brechot, Christian ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Chemical carcinogenesis; Cirrhosis; Cis activation; Co infection hepatitis B virus; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; P53; Protein Hbx; Transactivation

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ANIMAL MODEL; CHEMICAL CARCINOGENESIS; DISEASE ASSOCIATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; REVIEW; SUPERINFECTION; TRANSACTIVATION; VIRUS GENOME; VIRUS HEPATITIS; ANIMAL; GENETICS; HEPATITIS B; HEPATITIS C; LIVER TUMOR; VIROLOGY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; LIVER NEOPLASMS;

EID: 0033047011     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (127)

1. Tagger A, Donato F, Ribero M, Chiesa R, Tomasi V, Portera G, et al. A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. Brescia HCC study. Hepatology 1997;26:1653-7.
2. Abe K, Edamoto Y, Park Y, Nomura A, Taltavull T, Tani M, et al. In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions. Hepatology 1998;28:568-72.
3. Naoumov N, Petrova E, Thomas M, Williams R. Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet 1998;352:195-7.
4. Ganem D, Warmus HE. The molecular biology of the hepatitis virus. Annu Rev Biochem 1987;56:651-93.
5. Avantaggiati ML, Natoli G, Balsano C, Chirillo P, Artini M, De Marzio E, et al. The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements. Oncogene 1993;8:1567-74.
6. Hu KQ, Vierling M, Siddiqui A. Transactivation of HLA DR gene by hepatitis B virus X gene product. Proc Natl Acad Sci USA 1990;87:7140-4.
7. Twu JS, Schloemer RH. Transcriptional transactivating function of hepatitis B virus. J Virol 1987;61:3448-53.
8. Donello J, Becche A, Smith GJ, Lucero G, Hope T. The hepatitis B virus posttranscriptional regulatory element is composed of two subelements. J Virol 1996;70:4345-51.
9. Huang J, Liang T. A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol Cell Biol 1993;13:7476-86.
10. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
11. Beasley RP, Hwang LY. Overview on the epidemiology of hepatocellular carcinoma. In : Viral Hepatitis and Liver Diseases. Proceedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease : Contemporary Issues and Future Prospects. Baltimore, Md : Williams and Wilkins, 1991:532-5.
12. Kew M. Hepatocellular carcinoma with and without cirrhosis. Gastroenterology 1989;97:136-9.
13. Villeneuve J, Desrochers M, Infante-Rivard C, Willems B, Raymond G. Bourcier M, et al. A long-trem follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994;106:1000-5.
14. Chang M, Chen C, Lai M, Hsu H, Wu T, Kong M, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;336: 1855-9.
15. Liang TJ, Jeffers LJ, K.R. R, De Medina M, Parker IT, Cheinquer H, et al. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 1993;18:1326-33.
16. Paterlini P, Driss F, Pisi E, Franco D, Berthelot P, Bréchot C. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg negative patients : a study of a low endemic area. Hepatology 1993;17:20-9.
17. Sheu J-C, Huang G-T, Shih L-N, Lee W-C, Chou H-C, Wang J-T, et al. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992;103:1322-7.
18. Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992;16:637-41.
19. Su Q, Schroder C, Hofmann W, Otto G, Pichlmayr R, Bannasch P. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 1998; 27:1109-20.
20. Blum HE. Variants of hepatitis B, C and D viruses : molecular biology and clinical significance. Digestion 1995;56:85-95.
21. Feitelson MA. Biology of disease : Biology of hepatitis B virus variants. Lab Invest 1994;71:324-49.
22. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis : a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
23. Colombo M, De Franchis K, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-80.
24. Wang J, Chenivesse X, Henglein B, Brechot C. Hepatitis B virus integration in a cyclin A gene in a human hepatocellular carcinoma. Nature 1990;343:555-7.
25. Fausto N, Weber EM. Mechanisms of regulation in liver regeneration and hepatic carcinogenesis. In : Boyer JL, Ockner RK, eds. Progress in liver diseases. Philadelphia : WB Saunders, 1993:115-37.
26. Aihara T, Noguchi S, Sasaki Y, Nakano H, Monden M, Imaoka S. Clonal analysis of precancerous lesion of hepatocellular carcinoma. Gastroenterology 1996;111:455-61.
27. Le Bail B, Bioulac-Sage P, Tran van Nhieu J, Zafrani ES. Approche actuelle de la carcinogenèse hépatique. De la cirrhose au carcinome hépatocellulaire. Ann Pathol 1995;15:332-47.
28. Pontisso P, Morsica G, Ruvoletto MG, Barzon M, Perilongo G, Basso G, et al. Latent hepatitis B virus infection in childhood hepatocellular carcinoma. Cancer 1992;69:2731-5.
29. Yasui H, Hino O, Ohtake K, Machinami R, Kitagawa T. Clonal growth of hepatitis B virus integrated hepatocytes in cirrhotic liver nodules. Cancer Res 1992;52:6810-4.
30. Lugassy C, Bernuau J, Thiers V, Krosgaard K, Degott C, Wantzin P, et al. Sequences of hepatitis B virus DNA in the serum and liver of patients with acute benign and fulminant hepatitis. J Infect Dis 1987;155:64-71.
31. Dejean A, Bougueleret L, Grzeschik KH, Tiollais P. Hepatitis B virus DNA integration in a sequence homologous to v-erbA and steroid receptor genes in a hepatocellular carcinoma. Nature 1986;322:70-2.
32. Graef E, Caselman W, Wells J, Koshy K. Insertional activation of mevalonate kinase by hepatitis B virus DNA in a human hepatoma cell line. Oncogene 1994;9:81-7.
33. Saigo K, Chami M, Poussin K, Clepet C, Gyapay G, Caudron B, et al. Analyse d'intégration du génome du virus B dans le génome humain : activation en cis du gène SERCA 1 (Sarco Endoplasmic Reticulum Calcium ATPase) dans un cancer primitif du foie (résumé). Gastrenterol Clin Biol 1998;22 : A7.
34. Zhang Y, Fujii J, Phillips M, Chen H, Karpati G, Yee W, et al. Characterization of cDNA and genomic DNA encoding SERCA 1, the Ca(2+)-ATPase of human fast-twitch skeletal muscle sarcoplasmic reticulum, and its elimination as a candidate gene for Brody disease. Genomics 1995;30:415-24.
35. Fourel G, Trépo C, Bougueleret L, Henglein B, Ponzetto A, Tiollais P, et al. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature 1990;347:294-8.
36. Fourel G, Transy C, Tennant BC, Buendia MA. Expression of the woodchuck N-myc2 retroposon in brain and in liver tumors is driven by a cryptic N-myc promoter. Mol Cell Biol 1992;12:5336-44.
37. Balsano C, Avantaggiati ML, Natoli G, De Marzio E, Elfassi E, Will H, et al. Transactivation of c-fos and c-myc protooncogenes by both full-length and truncated versions of the HBV-X protein. In : Viral Hepatitis and Liver Disease. Proceedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease : Contemporary Issues and Future Prospects. Baltimore, Md : Williams and Wilkins, 1991:572-6.
38. Twu J, Lai M, Chen D, Robinson W. Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology 1993;192:346-50.
39. Natoli G, Avantaggiati ML, Chirillo P, Puri P, Ianni A, Balsano C, et al. Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 1994;9:2837-43.
40. Kekulé A, Lauer U, Weiss L, Luber B, Hofshneider P. Hepatitis B virus transactivator HBx uses a tumor promoter signalling pathway. Nature 1993;361:742-4.
41. Balsano C, Billet O, Bennoun M, Cavard C, Zider A, Grimber G, et al. The hepatitis B virus X gene product transactivates the HIV-LTR in vivo. Arch Virol 1993;8 Suppl : 63-71.
42. Wu JY, Zhou ZY, Judd A, Cartwright CA, Robinson WS. The hepatitis B virus-encoded transcriptional trans-activator HBx appears to be a novel protein serine/threonine kinase. Cell 1990;63:687-95.
43. Wang X, Forrester K, Yeh H, Feitelson M, Gu J, Harris C. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994;91:2230-4.
44. Sirma H, Weil R, Rosmorduc O, Urban S, Israel A, Kremsdorf D, et al. Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome. Oncogène 1998;16:2051-63.
45. Kim H, Lee H, Yun Y. X-gene product of hepatitis B virus induces apoptosis in liver cells. J Biol Chem 1998;273:381-5.
46. Chirillo P, Pagano S, Natoli G, Puri P, Burgio V, Balsano C, et al. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci USA 1997;94:8162-7.
47. Su F, Schneider R. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci USA 1997;94:8744-9.
48. Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, et al. High-level expression of hepatitis B virus HBx gene expression and hepatocarcinogenesis in transgenic mice. Hepatology 1994;19:810-9.
49. Kim C, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991;351:317-20.
50. Balsano C, Billet O, Bennoun M, Cavard C, Zider A, Grimber G, et al. Hepatitis B virus X gene product acts as a transactivator in vivo. J Hepatol 1994;21:103-9.
51. Lee TH, Finegold MJ, Shen RF, DeMayo JL, Woo SLC, Butel JS. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol 1990;64:5939-47.
52. Oguey D, Dumenco LL, Pierce RH, Fausto N. Analysis of the tumorigenicity of the X gene of the hepatitis B virus in a nontransformed hepatocyte cell line and the effects of the cotransfection with a murine p53 mutant equivalent to human codon 249. Hepatology 1996;24:1024-33.
53. Slagle B, Lee T, Medina D, Finegold M, Butel J. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinogen 1996;15:261-9.
54. Takada S, Kaneniwa N, Tsuchida N, Koike K. Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells. Oncogene 1997;15:1895-901.
55. Feitelson M, Ranganathan P, Clayton M, Zhang S. Partial characterization of the woodchuck tumor suppressor, p53, and its interaction with woodchuck hepatitis virus X antigen in hepatocarcinogenesis. Oncogene 1997;15:327-36.
56. Elmore L, Hancock A, Chang S, Wang X, Callahan C, Geller D, et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 1997;94:14707-12.
57. Ueda H, Ullrich SJ, Gangemi JD, Kappel C, Ngo I, Feitelson M, et al. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 1995;1995:41-7.
58. Wang W, London WT, Lega L, Feitelson MA. HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 1991;14:29-37.
59. Hsia C, Nakashima Y, Tabor E. Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma. Biochem Biophys Res Commun 1997;241:726-9.
60. Shaul Y, Garcia P, Schonberg S, Rutter W. Integration of hepatitis B virus DNA in chromosome specific satellite sequences. J Virol 1989;63:731-4.
61. Hino O, Kitagawa T, Koike K, Kobayashi M, Hara M, Mori W, et al. Detection of hepatitis B virus DNA in hepatocellular carcinomas in Japan. Hepatology 1984;4:90-5.
62. Henderson AS, Ripley S, Hino O, Rogler CE. Identification of a chromosomal aberration associated with a hepatitis B DNA integration site in human cells. Cancer Genet Cytogenet 1988;30:269-75.
63. Boige V, Laurent-Puig P, Fouchet P, Fléjou J, Monges G, Bedossa P, et al. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res. 1997;57:1986-90.
64. Nagai H, Pineau P, Tiollais P, Buendia M, Dejean A. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997;14:2927-33.
65. Boige V, Laurent-Puig P. Altération génétiques associées au carcinome hépatocellulaire. Gastroenterol Clin Biol 1997;21:34-44.
66. Hsu H, Peng S, Lai P, Sheu J, Chen D, Lin L, et al. Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients. Cancer 1996;73:42-7.
67. Coste A, Romagnolo B, Billuart P, Renard C, Buendia M, Soubrane O, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998;95:8847-51.
68. Pasquinelli C, Garreau F, Bougueleret L, Cariani E, Grzeschik KH, Thiers V, et al. Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors. J Virol 1988;62:629-32.
69. Slagle BL, Zhou YZ, Butel JS. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res 1991;51:49-54.
70. Rogler CE, Sherman M, Su CY, Shafritz DA, Summers J, Shows TB, et al. Deletion in chromosome lip associated with a hepatitis B integration site in hepatocellular carcinoma. Science 1985;230:319-22.
71. Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, et al. Allelotype study of primary hepatocellular carcinoma. Cancer Res 1991;51:89-93.
72. Zhang W, Hirohashi S, Tsuda H. Frequent loss of heterozygosity on chromosomes 4 and 16 in human hepatocellular carcinoma. Jpn J Cancer Res 1990;81:108.
73. Walker GJ, Hayward NK, Falvey S. Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res 1991;51:4367-70.
74. Korba BE, Wells FV, Baldwin B, Cote PJ, Tennant BC, Popper H, et al. Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks : presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections. Hepatology 1989;9:461-70.
75. Nalpas B, Bréchet C. The role of hepatitis viruses in the genesis of hepatocellular carcinoma in alcoholic cirrhotics. In : Watson, RR. ed. Alcohol and Cancer. Boca Raton : CRC, 1992:91-118.
76. Nalpas B, Berthelot P, Thiers V, Duhamel G, Courouce A, Tiollais P, et al. Hepatitis B virus multiplication in the absence of usual serological markers - A study of 146 alcoholics. J Hepatol 1985;1:89-97.
77. Nalpas B, Pourcel C, Feldmann G, Housset C, Tiollais P, Bréchet C, et al. Chronic alcohol intoxication decreases the serum level of hepatitis B surface antigen in transgenic mice. J Hepatol 1992;15:118-24.
78. Donato F, Tagger A, Chiesa R, Ribero M, Tomasoni V, Fasola M, et al. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma : a case-control study in Italy. Brescia HCC study. Hepatology 1997;26:579-84.
79. Lohmann V, Koch JO, Bartenschlager R. Processing pathways of the hepatitis C virus proteins. J Hepatol 1996;24(suppl 2) : 11-9.
80. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Bréchot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994;19:1321-4.
81. Bruix J, Banera J, Calvet X, Ercilla G, Costa J, Sanches-Tapias J, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;2:1004-6.
82. Simonetti RG, Cammà C, Fiorello F, Cottone M, Rapicetta M, Marino L, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Int Med 1992;116:97-102.
83. Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasi MA, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;2:1006-8.
84. Hasan F, Jeffers L, De Modina M, Reddy K, Parker T, Schiff E, et al. Hepatitis C associated hepatocellular carcinoma. Hepatology 1990;12:589-91.
85. Dazza MC, Meneses LV, Girard PM, Astagneau P, Villaroel C, Delaporte E, et al. Absence of a relationship between antibodies to hepatitis C virus and hepatocellular carcinoma in Mozambique. Am J Trop Med Hyg 1993;48:237-42.
86. DiBisceglie AM, Order SB, Klein JL, Choo QL, Hoofnagle JH. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 1991;86:335-8.
87. Sbolli G, Zanetti AR, Tanzi E, Cavanna L, Civardi G, Fornari F, et al. Serum antibodies to hepatitis C virus in Italian patients with hepatoeellular carcinoma. J Med Virol 1990;30:230-2.
88. Bukh J, Miller R, Kew M, Purcell R. Hepatitis C Virus RNA in southern African blacks with hepatocellular carcinoma. Proc Natl Acad Sci USA 1993;90:1848-51.
89. Lee S, Lee F, Wu J, Hwang S, Wang S, Lo K. The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma. Cancer 1992;69:342-5.
90. Lee H, Han C, Kim C. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in hepatitis-B endemic area. Cancer 1993;72:2564-7.
91. Leung N, Tam J, Lai J, Leung T, Lau W, Shiu W, et al. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong ? Cancer 1992;70:40-4.
92. Saito I, Miyamura T, Ohbayashi H, Harada H, Katayama T, Kikuci S, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:6547-9.
93. Miyagawa S, Kawasaki S, Makuuchi M. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection : tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology 1996;24:307-10.
94. Shiratori Y, Shiina S, Imamura M, Kato M, Kanai F, Okudaira T, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 1995;22:1027-33.
95. Takenaka K, Yamamoto K, Taketomi A, Itasaka H, Adachi E, Shirabe K, et al. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology 1995;22:20-4.
96. Kobayashi M, Tanaka E, Sodeyama T, Urushiara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C : a comparison between patients with genotype 1 and 2 hepatitis viruses. Hepatology 1996;23:695-9.
97. Gane E, Portmann B, Naoumov N, Smith H. Underhill J, Donaldson P, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;1996:815-20.
98. Féray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1089-96.
99. Bruno S, Silini E, Rossi S, Bono F, Borzio F, Leandro G, et al. HCV genotype 1b is a major risk factor for the development of hepatocellular carcinoma (HCC) in cirrhotic patients : a prospective study. J Hepatol 1995;23(suppl 1) : 111.
100. De Mitri M, Poussin K, Baccarini P, Pontisso P. D'Errico A, Simon N, et al. HCV-associated liver cancer without cirrhosis. Lancet 1995;354:413-415.
101. Reid A, Jeffers L, Reddy K, Aiza I, Schiff E, Dienstag J, et al. Hepatitis C virus genotypes and hepatocellular carcinoma. Hepatology 1994;20:250A.
102. Nousbaum J-B, Pol S, Nalpas B, Landais P, Berthelot P, Bréchet C. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995;122:161-8.
103. Naoumov N, Chokchi S, Metivier E, Maertens G, Johnson P, Williams R. Hepatitis C virus genotypes and hepatocellular carcinoma. Hepatology 1994;20:250A.
104. Benvegnu L, Alberti A. Risk factors and prevention of hepatocellular carcinoma in HCV infection. Dig Dis Sci 1996;41:49S-55S.
105. Takano S, Yokosura O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C : a prospective study of 251 patients. Hepatology 1995;21: 650-5.
106. Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakuma S, et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Hepatology 1998;27:1394-402.
107. Bruno S, Silini E, Crosignani A, Borzio F, Leandro G, Bono F, et al. Hepatitis C virus genotype and risk of hepatocellular carcinoma in cirrhosis : a prospective study. Hepatology 1997;25:754-8.
108. Hino O, Kajino K. Hepatitis virus-related hepatocarcinogenesis. Intervirology 1994;37:133-5.
109. Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus non structural protein NS3 transform NIH3T3. J Virol 1995;69: 3893-6.
110. Kim DW, Susuki R, Harada T, Saito I, Miyamura T. Trans-suppression of gene expression by hepatitis C viral core protein. Jpn J Med Sci Biol 1994;47:211-20.
111. Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S. p53 Gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcino-genesis. Cancer Res 1994;54:231-5.
112. Ray R, Lagging L, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 1996;70:4438-43.
113. Ray R, Steele R, Meyer K, Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 1997;272:10983-6.
114. Ray R, Steele R, Meyer K, Ray R. Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene 1998; 208:331-6.
115. Borowski P, Oehlman K, Heiland M, Lauf R. Nonstructural protein 3 of hepatitis C virus blocks the distribution of the free catalytic subunit of cyclic AMP-dependent proetin kinase. J Virol 1997;71:2838-43.
116. Gale MJ, Korth M, Tang N, Tan S, Hopkins D, Dever T, et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997;230:217-27.
117. Chung K, Song O, Jang S. Hepatitis C virus nonstructural protein 5A contains potential transcriptional activator domains. Mol Cells 1997;7:661-7.
118. Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG. Tumor suppressor function of the interféron-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 1993;90:232-6.
119. Nishiguchi S, Kuroki T, Yabusako T, Seki S, Kobayashi K, Monna T, et al. Detection of hepatitis C virus antibodies and hepatitis C virus RNA patients with alcoholic liver disease. Hepatology 1991;14:985-9.
120. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, el al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993;105: 1529-33.
121. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YHW. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH7 cells. J Virol 1993;67:5823-32.
122. Tsai J, Jeng J, Ho M, Chang W, Hsieh M, Lin Z, et al. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma : a prospective study. Br J Cancer 1997;76:968-74.
123. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B et C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998;75:347-54.
124. Urashima T, Saigo K, Kobayashi S, Imaseki H, Matsubara H, Koide Y, et al. Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues. J Hepatol 1997;26:771-8.
125. Sell S, Hunt JM, Dunsford HA, Chisari FV. Synergy between hepatitis B virus expression and chemical hepatocarcinogenesis in transgenic mice. Cancer Res 1992;51:1278-85.
126. Lee SM, Portmann BC, Margison GP. Abnormal intracellular distribution of 06-alkylguanine-DNA-Alkyltransferase in hepatitis B cirrhotic human liver : a potential cofactor in the development of hepatocellular carcinoma. Hepatology 1996;24: 987-90.
127. Collier JD, Bassendine MF, Burt AD, Major GN. Characterization of the DNA repair enzyme for O(6)-methylguanine in cirrhosis. J Hepatol 1996;25:158-65.